New tool aims to predict esophageal cancer outcomes, guide care
NCT ID NCT07488624
Summary
This study looked back at the medical records of 414 patients with esophageal cancer who had received a specific combination of drug therapy before surgery. The goal was to create a new prediction model that uses details from a patient's tumor and treatment response to estimate their long-term survival chances. Researchers hope this model will help doctors make more personalized decisions about what treatments, if any, a patient might need after their initial surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESCC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.